View Pages
Morning Minute: JPMorgan, UnitedHealth Beat, J&J Guidance
Premarket snapshot: JPMorgan action, UnitedHealth beats earnings, Johnson & Johnson updates guidance—implications for bank and healthcare stocks.
Editorial companion
What stands out
Jenny Kovacs ran a brisk premarket check on three market movers: bank earnings activity around JPMorgan, a UnitedHealth Group earnings beat, and fresh guidance from Johnson & Johnson. The clip highlights UnitedHealth’s better-than-expected quarter and J&J’s updated outlook as the concrete headlines traders were parsing before the open. That snapshot explains the morning’s short-term price action and why healthcare and financial names were at the top of screeners during the premarket session.
View Pages
Bullish Gator Snapshot
Current ratings and signals
Johnson & Johnson (JNJ)
Neutral
JNJ rates Neutral overall. The fundamental read is neutral: the company passes 3 of 9 quality tests on the Piotroski F-Score; balance sheet is in the Safe zone (Altman Z = 5.49); revenue is declining about 0.0% per year; net income is growing about 42.2% per year. The technical picture is bullish: price is 10.0% above the 200-day moving average; 1.3% above the 50-day; the 50/200 relationship is in a Golden cross. Sentiment is bullish (composite 72/100), based on 8 news articles from recent coverage.
UnitedHealth Group (UNH)
Bullish
UNH rates Bullish overall. The fundamental read is neutral: the company passes 6 of 9 quality tests on the Piotroski F-Score; balance sheet is in the Safe zone (Altman Z = 3.07); revenue is growing about 11.4% per year; net income is declining about 13.6% per year. The technical picture is bullish: price is 14.5% above the 200-day moving average; 5.7% above the 50-day; the 50/200 relationship is in a Golden cross. Sentiment is bullish (composite 78/100), based on 5 news articles from recent coverage.